Skip to Main Content

public health

STAT reports on the people, policies and providers in the public health sector. Recent articles range from vaccine issues and outbreak monitoring to ambitious proposals on safe drinking water and hepatitis C.

Latest

Business Lizzy Lawrence

STAT Plus: 3 key issues to watch at the FDA as Trump takes office

First Opinion Torie Bosch

The most read First Opinion essays of 2024

First Opinion Anand Parekh, William Dietz, and Joseph Nadglowski

Extending Medicare coverage to obesity medications is imperative

Politics John Wilkerson

STAT Plus: GOP works to square making America healthy with taking away health insurance

Health Helen Branswell

STAT Plus: How Jimmy Carter’s global health efforts elevated ‘the art of the possible’

In the Lab Kay Lazar — Boston Globe

STAT Plus: ‘There is a lot more anxiety here’: Scientists brace for shake-ups to health funding under Trump

Health Anil Oza

People from India remember life before the polio vaccine. They don’t want to go back

Don't Miss STAT Staff

We wish we’d written that: STAT staffers share their favorite stories of 2024

All Coverage

Health Helen Branswell

Three issues to watch in global health in 2025

Don't Miss Alissa Ambrose and Crystal Milner

STAT’s most memorable photos of 2024

advertisement

Health Annalisa Merelli

Maternal mortality data is murky — but the crisis faced by new moms is clear

Business Lizzy Lawrence and Elizabeth Cooney

STAT Plus: FDA updates rules for which foods are ‘healthy,’ adding salmon and nuts and cutting sugary cereals

Pharmalot Ed Silverman

STAT Plus: Feds accuse CVS of filling ‘thousands’ of illicit opioid prescriptions

Pharmalot Ed Silverman

STAT Plus: Health plan formularies lowered barriers to fair access to some drugs, analysis finds

First Opinion Craig Spencer and Nahid Bhadelia

The DRC ‘mystery illness’ shows why the U.S. can’t ‘pause’ infectious disease work

Health Helen Branswell

CDC confirms first known severe case of H5N1 bird flu in the U.S.

Politics Sarah Owermohle, John Wilkerson, and Rachel Cohrs Zhang

STAT Plus: Republicans show no signs of blocking Trump’s health secretary pick RFK Jr. so far

D.C. Diagnosis Sarah Owermohle

STAT Plus: PBMs face scrutiny from all sides, and analyzing Marty Makary’s road to the FDA

Politics Lizzy Lawrence

STAT Plus: Truth-teller or reflexive contrarian: Which Marty Makary would run the FDA?

Politics Rachel Cohrs Zhang

STAT Plus: Congress strikes deal to rein in PBMs after years of debate

Morning Rounds Theresa Gaffney

An exit interview with CDC director Mandy Cohen

Politics Helen Branswell

STAT Plus: Outgoing CDC director girds against an overhaul, and tries to calm staff nerves

Pharmalot Ed Silverman

STAT Plus: South African regulator decides Vertex provides sufficient access to CF drugs, angering activists

Morning Rounds Brittany Trang

The conclusion(?) to the bird flu mystery and a Syrian doctor on coming to the U.S.

Pharmalot Ed Silverman

STAT Plus: Tuberculosis R&D funding is up, but still short of goals and dominated by a few players, report finds

First Opinion Akshara Ramasamy

In a threat to patient trust, Texas hospitals must ask ‘Are you a U.S. citizen?’

Health Helen Branswell

Case of possible bird flu in California remains murky, and may stay that way

Pharmalot Ed Silverman

STAT Plus: Wall Street wags say a bill to force insurers or PBMs to sell pharmacies has low odds

Health Lev Facher

STAT Plus: Biden officials take credit for ‘largest drop’ in overdose deaths. Experts are more cautious